Zenta Hosts Annual Meeting, Reveals IPO Plans

Zenta Hosts Annual Meeting, Reveals IPO Plans

On June 13, Zenta Group recently held its annual meeting in the Macau Tower Conference Hall. Chairman, Wu Wei En, shared the company’s visions and plans, including the launch of its US listing plan. The IPO is expected to complete in the first half of 2024, with ARC Group as sole financial advisor.

 

Zenta annual meeting

Our Managing Director, Edward Sit, and Vice President, Nigel Wong, from the Hong Kong office attended the event, representing ARC Group. Thank you to Zenta Group for hosting this event and to everyone we had the pleasure to meet. Looking forward to fostering these relationships and the next steps in Zenta Group’s journey.

Continue reading

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

ARC Group Announces US$15 Million Investment Commitment in Cloudbreak Pharma Inc. (HKEX: 2592)

HONG KONG, 18 June 2026 — ARC Group today announced that it has committed to invest in Cloudbreak Pharma Inc. (HKEX: 2592), a clinical-stage ophthalmology biotechnology company with operations across the United States and China, following the signing of a share subscription agreement through its wholly owned subsidiary ARC Group International Limited. The transaction marks […]
Rising Together | ARC Dragon Boat Team Takes to the Water
Bio Green Med Solution, Inc. Announces Business Combination Agreement to Acquire Future NRG Sdn. Bhd.
Inside ARC Group | University of Nottingham Ningbo China

Please complete this form to download the case study

This field is for validation purposes and should be left unchanged.
*Required before submission